The effect of peroxisome proliferatoractivated receptor-c ligands on in vitro and in vivo models of COPD

83Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Peroxisome proliferator-activated receptor (PPAR)-c is expressed in alveolar macrophages. The anti-inflammatory potential of the PPAR-c ligands rosiglitazone and pioglitazone were investigated using in vitro alveolar macrophage models and in vivo animal models relevant to chronic obstructive pulmonary disease (COPD). PPAR-c protein and gene expression in COPD alveolar macrophages was compared with control smokers and never-smokers. COPD macrophages were used to investigate the effects of PPAR-c ligands and corticosteroids on lipopolysaccharide-induced cytokine production, alternative macrophage activation (M2) gene expression and efferocytosis. The effects of PPAR-c ligands in a subchronic tobacco smoke model in mice were investigated. PPAR-c protein expression was similar in COPD patients compared to controls, although increased gene expression levels were observed in COPD patients and control smokers compared to never-smokers. PPAR-c ligands reduced tumour necrosis factor-a and CC chemokine ligand-5, but not CXC chemokine ligand-8, in COPD alveolar macrophages; these effects were generally less than those of the corticosteroid dexamethasone. Rosiglitazone increased M2 gene expression and enhanced efferocytosis of apoptotic neutrophils. Rosiglitazone and pioglitazone attenuated airway neutrophilia in a corticosteroid-resistant mouse model of pulmonary inflammation. We show biological actions of PPAR-c agonists on corticosteroid-resistant disease, tobacco smokeinduced pulmonary inflammation, skewing of macrophage phenotype and clearance of apoptotic neutrophils. Copyright © ERS 2014.

References Powered by Scopus

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes

4310Citations
N/AReaders
Get full text

The nature of small-airway obstruction in chronic obstructive pulmonary disease

3168Citations
N/AReaders
Get full text

15-Deoxy-Δ<sup>12</sup>,<sup>14</sup>-Prostaglandin J<inf>2</inf> is a ligand for the adipocyte determination factor PPARγ

2767Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Targeting cell signaling in allergic asthma

230Citations
N/AReaders
Get full text

Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis

223Citations
N/AReaders
Get full text

PPAR γ and the Innate Immune System Mediate the Resolution of Inflammation

192Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lea, S., Plumb, J., Metcalfe, H., Spicer, D., Woodman, P., Fox, J. C., & Singh, D. (2014). The effect of peroxisome proliferatoractivated receptor-c ligands on in vitro and in vivo models of COPD. European Respiratory Journal, 43(2), 409–420. https://doi.org/10.1183/09031936.00187812

Readers over time

‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

52%

Researcher 6

26%

Professor / Associate Prof. 4

17%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 8

44%

Biochemistry, Genetics and Molecular Bi... 4

22%

Medicine and Dentistry 3

17%

Immunology and Microbiology 3

17%

Save time finding and organizing research with Mendeley

Sign up for free
0